ÇòʸĻ¥Ô¥Ômeʪ¸ì

¸¡»¡¤ÈÂç¼ê¥á¥Ç¥£¥¢¤ÎÌÀ¤é¤«¤ÊÈȺá

²áµî¤ÎÅê¹ÆÆüÊÌɽ¼¨

[ ¥ê¥¹¥È | ¾ÜºÙ ]

Á´1¥Ú¡¼¥¸

[1]


ÆÉÇ俷ʹ¤Ï¡¢´Ú¹ñ¤Î¹¿Æï´ð¡Ê¥Û¥ó¥Ê¥à¥®¡Ë·ÐºÑÉû¼óÁê¤Îȯ¸À¤ò¡ÖÆüËܤËÂй³Á¼ÃÖ¤â¡×¡ÖÌÀÇò¤Ê·ÐºÑÊóÉü¡×¤È¾Î¤·¤Æ¤¤¤ë¤¬¡¢¹¿Æï´ðÉû¼óÁê¤Ï¡¢¡ÖÆüËܤËÂй³Á¼ÃÖ¤â¡×¤È¸À¤Ã¤Æ¤¤¤ë¤¬¡ÖÌÀÇò¤Ê·ÐºÑÊóÉü¡×¤È¤Ï¸À¤Ã¤Æ¤¤¤Ê¤¤¡£

¤Ç¤Ï¡¢¹¿Æï´ðÉû¼óÁê¤Î¾§¤¨¤ë¡ÖÆüËܤËÂй³Á¼Ã֡פȤϲ¿¤«¡©

Åú¤¨¤ÏÌÀ³Î¤Ç¤¢¤ë¡£
¥µ¥¤¥Ð¡¼¥Æ¥í¤Ç¤¢¤ë¡£

´Ú¹ñ¡¢Ê¸ºßÆÒ¡Ê¥à¥ó¡¦¥¸¥§¥¤¥ó¡ËÂçÅýÎΤ¬¡¢Èà¤Î¿®Êô¤¹¤ëËÌÄ«Á¯¤Î¶âÀµ²¸¡Ê¥­¥à¡¦¥¸¥ç¥ó¥¦¥ó¡ËÄ«Á¯Ï«Æ¯ÅްѰ÷Ť˰ÍÍꤷ¤¿¤é¤¤¤¤¤À¤±¤ÎÏá£

ÆüËܤËÀø¤ê¹þ¤ó¤Ç¤¤¤ë¥¹¥Ñ¥¤¤ÏÆîËÌÄ«Á¯¹ç¤ï¤»¤Æ¶²¤é¤¯¾¯¤Ê¤¯¤È¤â£±£°Ëü¿Í¤Ï¤¤¤ë¤À¤í¤¦¡£¤½¤ì¤âÀ¯Éܵ¡´Ø¤ÏÅöÁ³¤Î¤³¤È¡¢Âç³Ø¤Î¸¦µæµ¡´Ø¤ä̱´Ö´ë¶È¤Ê¤É¤Î¤¢¤é¤æ¤ëʬÌî¤Ë¼Ò°÷¤È¤·¤Æ¡¢°¿¤¤¤Ï²¼ÀÁ¤±¤È¤·¤ÆÀø¤ó¤Ç¤¤¤ë¡£

¤³¤ÎÆîË̤Υ¹¥Ñ¥¤¤¿¤Á¤¬Åð¤ß¼è¤Ã¤¿ÆüËܤξðÊó¤ò¹ç»»¤¹¤ë¤ÈÆüËܤÏÁêÅö¤ÊÂÇ·â¤òÈï¤ë¤À¤í¤¦¡£

Î㤨¤ÐNHK¤Î»±²¼¡ØNHK¥¨¥ó¥¿¡¼¥×¥é¥¤¥º£²£±¡Ù¤Ç¤ÏËÌÄ«Á¯·³»öµ¡Ì©¥¹¥Ñ¥¤¤¬Æ²¡¹¤È¥×¥í¥Ç¥å¡¼¥µ¡¼¤ò¤·¤Æ¤¤¤ë¡£Î®ÀС¢¥³¥ê¥¢¥ó£Î£È£Ë¡£

°¿¤¤¤Ï¡¢¥Î¡¼¥Æ¥ó¥­¤Ç̵ËÉÈ÷¤Ê»°É©¤ÇɽÌ̲½¤·¤¿»ö·ï¤Ï¡¢É¹»³¤Î°ì³Ñ¤Ë¤¹¤®¤Ê¤¤¡£¼«±ÒÂâ¤Îµ¡Ì©¾ðÊ󤬤À¤Àϳ¤ì¡£

Φ¾å¼«±ÒÂâ¤ÎºÇ¿··¿ÃÏÂжõ¥ß¥µ¥¤¥ë¥·¥¹¥Æ¥à¡ÊÃæSAM¡Ë¤Ë´Ø¤¹¤ë¸¦µæ¤òÀÁ¤±Éé¤Ã¤Æ¤¤¤¿»°É©Áí¹ç¸¦µæ½ê¤¬Àï½ÑÃÆÆ»ÃÆ¡ÊTMB¡Ë¤Ø¤ÎÂнèǽÎϤÎÀ­Ç½¤Ê¤É¤ò¸¡Æ¤¤¹¤ë°Ù¤ËºîÀ®¤·¤¿ÃæSAM¤ÎŸ³«¡¦±¿Íѹ½ÁÛ¡¦Í×·â¹âÅÙ¡¦Í×·âµ÷Î¥¡¦±ç¸îÈϰϤʤɤ˴ؤ¹¤ë¿ôÃͤäŨµ¡ÀïÆ®Çú·âµ¡¤ËÂФ¹¤ëÀ­Ç½¿ôÃͤʤɤÎÊó¹ð½ñºîÀ®¶È̳¤òË¿¥½¥Õ¥È¥¦¥§¥¢²ñ¼Ò¤Ë°ÑÂ÷¤·¤¿¡£

¤³¤Î°ÑÂ÷¤·¤¿²ñ¼Ò¤¬ËÌÄ«Á¯¤Î²Ê¶¨´ØÏ¢´ë¶È¤Ç¡¢ËÌÄ«Á¯¤Ø¤ÎÉÔÀµÍ¢½Ð»ö·ï¤ÇÂáÊᤵ¤ì¤¿£²¿Í¤¬Ìò°÷¤ò̳¤á¤ë²ñ¼Ò¤Ê¤Î¤À¡£

¡Ê°Ê¾å¤Ï¡Ë
NHK¤ÈËÌÄ«Á¯¥¹¥Ñ¥¤ÁÈ¿¥¤È¤Î´Ø·¸¡Ê2014/11/26(¿å) ¡Ë¤è¤ê


´Ú¹ñÉû¼óÁê¡ÖÆüËܤËÂй³Á¼ÃÖ¤â¡×¡ÖÌÀÇò¤Ê·ÐºÑÊóÉü¡×

ÆÉÇ俷ʹ¡¡7/4(ÌÚ) 11:23ÇÛ¿®

¡¡¡Ú¥½¥¦¥ë¡á²¬ÉôͺÆóϺ¡Û´Ú¹ñ¤Î¹¿Æï´ð¡Ê¥Û¥ó¥Ê¥à¥®¡Ë·ÐºÑÉû¼óÁê¤Ï£´Æü¸áÁ°¡¢ÆüËÜÀ¯Éܤˤè¤ëȾƳÂÎÁǺà¤ÎÂдÚÍ¢½Ðµ¬À©¶¯²½¤ËÉÔÉþ¤òɽÌÀ¤·¡¢¡Öű²ó¤·¤Ê¤±¤ì¤Ð¡¢ÆüËܤËÂФ·¤ÆÁê±þ¤ÎÁ¼ÃÖ¤ò¸¡Æ¤¤¹¤ë¡×¤ÈÂй³Á¼ÃÖ¤ò¼¨º¶¤·¤¿¡£´Ú¹ñ¡¦£Ã£Â£Ó¥é¥¸¥ª¤Î¥¤¥ó¥¿¥Ó¥å¡¼¤Ç¸ì¤Ã¤¿¡£

¡¡¹¿»á¤Ï¡¢Í¢½Ðµ¬À©¶¯²½¤ÏħÍѹ©ÌäÂê¤ò½ä¤ëÆüËܦ¤Î¡ÖÌÀÇò¤Ê·ÐºÑÊóÉü¡×¤À¤È²þ¤á¤ÆÈóÆñ¤·¤¿¡£À¤³¦Ëǰ׵¡´Ø¡Ê£×£Ô£Ï¡Ë¤Ø¤ÎÄóÁʤνàÈ÷¤ò¿Ê¤á¤Æ¤¤¤ë¤È¤·¤¿¾å¤Ç¡Ö£×£Ô£Ï¤Î·ë²Ì¤¬½Ð¤ë¤Þ¤Ç¤Ë¤ÏŤ¤ºÐ·î¤¬¤«¤«¤ë¡£¤½¤ì¡ÊÄóÁʡˤ¬Í£°ì¤ÎÂбþ¤È¤¤¤¦¤³¤È¤Ë¤Ï¤Ê¤é¤Ê¤¤¡×¤È¤â½Ò¤Ù¤¿


As Trump and Kim Met, North Korean Hackers Hit Over 100 Targets in U.S. and Ally Nations
By Nicole Perlroth
¥Ë¥å¡¼¥è¡¼¥¯¥¿¥¤¥à¥º
March 3, 2019

¥È¥é¥ó¥×¤È¥­¥à¤¬²ñ¤Ã¤Æ¤¤¤ë»þ¡¢ËÌÄ«Á¯¤Î¥Ï¥Ã¥«¡¼¤¬¥¢¥á¥ê¥«¤äƱÌÁ¹ñ¤Î100°Ê¾å¤ÎɸŪ¤ò¹¶·â

Nicole PerlrothÃø
¥Ë¥å¡¼¥è¡¼¥¯¥¿¥¤¥à¥º
2019ǯ3·î3Æü

North Korean hackers targeted banks, utilities and energy companies in the United States and Europe over the last 18 months, according to the security firm McAfee. New York, a financial hub, was a major target.CreditCreditTodd Heisler/The New York Times

¥»¥­¥å¥ê¥Æ¥£²ñ¼ÒMcAfee¤Ë¤è¤ë¤È¡¢ËÌÄ«Á¯¤Î¥Ï¥Ã¥«¡¼¤Ï²áµî18¥ö·î´Ö¤ËÊÆ¹ñ¤È¥è¡¼¥í¥Ã¥Ñ¤Î¶ä¹Ô¡¢¸ø±×»ö¶È¤ª¤è¤Ó¥¨¥Í¥ë¥®¡¼²ñ¼Ò¤òɸŪ¤È¤·¤Æ¤¤¤¿¡£¶âÍ»¤ÎÃæ¿´ÃϤǤ¢¤ë¥Ë¥å¡¼¥è¡¼¥¯¤¬Â礭¤Ê¥¿¡¼¥²¥Ã¥È¤Ç¤·¤¿¡£CreditCreditToddHeisler / The New York Times

SAN FRANCISCO — North Korean hackers who have targeted American and European businesses for 18 months kept up their attacks last week even as President Trump was meeting with North Korea¡Çs leader in Hanoi.

¥µ¥ó¥Õ¥é¥ó¥·¥¹¥³ - ¥È¥é¥ó¥×ÂçÅýÎΤ¬ËÌÄ«Á¯¤Î¥Ï¥Î¥¤¤Î»ØÆ³¼Ô¤È²ñÃ̤·¤Æ¤¤¤¿¤È¤·¤Æ¤â¡¢18¥õ·î´Ö¥¢¥á¥ê¥«¤È¥è¡¼¥í¥Ã¥Ñ¤Î¥Ó¥¸¥Í¥¹¤òɸŪ¤Ë¤·¤¿ËÌÄ«Á¯¤Î¥Ï¥Ã¥«¡¼¤Ï¹¶·â¤ò³¤±¤Þ¤·¤¿¡£¡Ê°Ê¸å¾Êά¡Ë

ËÌÄ«Á¯¤Î¡È¹ñ²È»Ù±ç·¿¡É¥µ¥¤¥Ð¡¼¹¶·â¥°¥ë¡¼¥×¡¢ÆüËܤòÁÀ¤¦¡ÖAPT37¡×¤È¶âÍ»µ¡´Ø¤òɸŪ¤Ë¤¹¤ë¡ÖAPT38¡×¡¡°ëë ÃÒ¿Î2019ǯ4·î23Æü 
¡¡¥Õ¥¡¥¤¥¢¡¦¥¢¥¤³ô¼°²ñ¼Ò¤Ï¡¢Ç¯´Ö¤Î¥»¥­¥å¥ê¥Æ¥£Æ°¸þ¤ò¤Þ¤È¤á¤¿¡ÖMandiant M-Trends 2019¡×¥ì¥Ý¡¼¥È¤ò¸ø³«¤·¤¿¡£À¯Éܵ¡´Ø¤Ê¤É¤òɸŪ¤Ë¤·¤¿APT¡ÊAdvanced Persistent Threat¡Ë¹¶·â¥°¥ë¡¼¥×¤ÎºÇ¿·Æ°¸þ¤ÈƱ¼Ò¥ì¥Ã¥É¥Á¡¼¥à¤Î³èư¤«¤éÆÀ¤é¤ì¤¿Ãθ«¤Ê¤É¤ò¾Ò²ð¤·¤Æ¤¤¤ë¡£

ÌÜŪ¤¬°Û¤Ê¤ë2¤Ä¤Î¹¶·â¥°¥ë¡¼¥×¡¢ËÌÄ«Á¯¤Î¡ÖAPT37¡×¡ÖAPT38¡×
¡¡¹ñ²ÈÁÈ¿¥¤Î»Ù±ç¤ò¼õ¤±¤Æ¥µ¥¤¥Ð¡¼¹¶·â¤ò»Å³Ý¤±¤ë¥°¥ë¡¼¥×¤Ï¡ÖAPT¡Ê¿ô»ú¡Ë¡×¤È¤¤¤¦Ì¾¾Î¤Ç¼±Ê̤µ¤ì¤Æ¤¤¤ë¤¬¡¢º£²ó¤Î¥ì¥Ý¡¼¥È¤Ç¤ÏËÌÄ«Á¯¤Î¡ÖAPT37¡×¤ª¤è¤Ó¡ÖAPT38¡×¡¢¥¤¥é¥ó¤Î¡ÖAPT39¡×¡¢Ãæ¹ñ¤Î¡ÖAPT40¡×¤¬¿·¤¿¤ËÄɲ䵤줿¡£

¡¡APT37¤ÏÊÌ̾¡ÖReaper¡×¤È¸Æ¤Ð¤ì¤Æ¤¤¤ë¡£·³»ö¤äÀ¯¼£¡¢·ÐºÑ¤ËÂФ¹¤ëËÌÄ«Á¯¤ÎÀïÎ¬ÅªÍø±×¤Ë¤Ä¤Ê¤¬¤ë¾ðÊó¤Î¼ý½¸¤ò¹Ô¤¦·¹¸þ¤¬¤¢¤ê¡¢2012ǯ¤«¤é³èư¤·¤Æ¤¤¤ë¤È¤ß¤é¤ì¤Æ¤¤¤ë¡£

Åö½é¤Ï´Ú¹ñ¤ÎÁÈ¿¥¤òɸŪ¤Ë¤·¤Æ¤¤¤¿¤¬¡¢2017ǯ°Ê¹ß¤ÏÆüËÜ¡¢¥Ù¥È¥Ê¥à¡¢ÃæÅìÃÏ°è¤Ø¤È¹¶·âÂоݤò³ÈÂ礷¤¿¡£À½Â¤¡¢¹Ò¶õ±§Ãè¡¢¼«Æ°¼Ö¡¢°åÎŵ¡´Ø¤Ê¤É¤Î¶È¼ï¤òɸŪ¤·¤Æ¤¤¤ë¡£

¤Þ¤¿¡¢´Ú¹ñ¤Î´±¸øÄ£¤ä̱´ÖÁÈ¿¥¡¢ËÌÄ«Á¯¤«¤é¤ÎË´Ì¿¼Ô¤ä¿Í¸¢³èư²È¤âɸŪ¤È¤·¤Æ¤¤¤ëÅÀ¤«¤é¡¢Æ±¥°¥ë¡¼¥×¤Î³èưÆâÍÆ¤¬ËÌÄ«Á¯¤ÎÍø³²¤Ë°ìÃפ·¤Æ¤¤¤ë¤È¤¤¤¦¡£

¡¡°ìÊý¡¢APT38¤Ï¶âÁ¬Àà¼è¤òÌÜŪ¤Ë¡¢À¤³¦Ãæ¤Î¶âÍ»µ¡´Ø¤Ø¹¶·â¤ò»Å³Ý¤±¤Æ¤¤¤ë¤Î¤¬ÆÃħ¡£Ä¹´üŪ¤Ê·×²è¤Ë´ð¤Å¤¤¤Æ³èư¤·¤Æ¤ª¤ê¡¢ÌÜŪãÀ®¸å¤ÏŰÄ줷¤¿Ç˲õ³èư¤ÇÄ´ºº¤Î˸³²¤â¹Ô¤¦¡£

¶âÍ»µ¡´Ø¤«¤éÀà¼è¤ò»î¤ß¤¿¶â³Û¤Ï2015ǯ°Ê¹ß¤Ë¿ô²¯¥É¥ëµ¬ÌϤ˾å¤ê¡¢2016ǯ¤Ë¤Ï¥Ð¥ó¥°¥é¥Ç¥·¥å¤ÎÃæ±û¶ä¹Ô¤«¤é8100Ëü¥É¥ë¤òÅð¤ß¼è¤Ã¤¿»öÎ㤬¤¢¤ë¡£¤Ê¤ª¡¢APT38¤Ï¹ñ²È»Ù±ç¤ò¼õ¤±¤Æ¤¤¤ëAPT¥°¥ë¡¼¥×¤ÎÃæ¤Ç¤â¶âÁ¬Àà¼è¤òÌÜŪ¤Ë³èư¤·¤Æ¤¤¤ëÍ£°ì¤Î¥°¥ë¡¼¥×¤Ë¤Ê¤ë¤È¤¤¤¦¡£

¡¡APT37¤ÈAPT38¤Ï¡¢½é´üÃʳ¬¤Ç¤Ï¼«¹ñÆâ¤Ç¤Î³èư¤ò½¸ÃæÅª¤Ë¹Ô¤Ã¤Æ¤¤¤¿¤¬¡¢ºÇ¶á¤Ç¤Ï¡ÖÆüËܤʤÉÃÏÀ¯³ØÅª¤Ë´Ø·¸¤Î¿¼¤¤¹ñ¤òɸŪ¤Ë¹¶·â¤ò³ÈÂ礷¤Æ¤¤¤ë¡×¤È¥Õ¥¡¥¤¥¢¡¦¥¢¥¤¤ÎÀéÅÄŸÌé»á¡Ê¥·¥Ë¥¢¥¤¥ó¥Æ¥ê¥¸¥§¥ó¥¹¥¢¥«¥¦¥ó¥È¥¢¥Ê¥ê¥¹¥È¡Ë¤ÏÀâÌÀ¤¹¤ë¡£¡Ê°Ê¸å¾Êά¡Ë

¿·»þÂ奵¥¤¥Ð¡¼ÀïÁè¤Ï˽Áö¤¹¤ë
A New Age of Cyberwar
2019ǯ7·î3Æü¡Ê¿å¡Ë18»þ10ʬ
¥Õ¥ì¥Ã¥É¡¦¥«¥×¥é¥ó¡Ê¥¹¥ì¡¼¥È»ï¥³¥é¥à¥Ë¥¹¥È¡Ë

£í

ÂçÁû¤®¤ò¤¹¤ëÆüËܤȴڹñ¤Î¥Þ¥¹¥á¥Ç¥£¥¢¡£

¡Ö´Ú¹ñ¤ËÂФ¹¤ëÍ¢½Ðµ¬À©È¯Æ°¡×¤Ï¡¢È¾Æ³ÂκàÎÁ¤ÎÍ¢½ÐÆþ¤Ë´Ø¤·¤Æ¤Ï¡¢²¿¤é±Æ¶Á¤¬Ìµ¤¤¡£¤¿¤À¡¢³µ¤·¤Æ¸À¤¨¤Ð½ñÎबÁý¤¨¤ë¤À¤±¤À¡£Í¢½ÐÆþ¼ê³¤­¤¬EU¤ÎÂдÚÍ¢½Ðµ¬À©¤ÈƱ¤¸¤Ë¤Ê¤ë¤À¤±¤À¡££²£°£°£´Ç¯¤Î¾õ¶·¤ËÌ᤹¤À¤±¡£

¨¤Á¡¢´Ú¹ñÀ¯Éܤ¬£×£È£Ï¤ËÁʤ¨¤¿¤é¡¢ÃѤò¤«¤¯¤Î¤Ï´Ú¹ñÀ¯ÉÜ¡£

²æÅù»ëİ¼Ô¤Ï¤Þ¤ó¤Þ¤ÈñÙ¤µ¤ì¤¿¡£
´Ú¹ñÀ¯ÉܤÎÍ×˾¤Ë±è¤Ã¤¿ÆüËܤΥޥ¹¥á¥Ç¥£¥¢¤Ë¡ª
¤³¤ì¤¬ÆüËܤΥޥ¹¥á¥Ç¥£¥¢¤Î¼ÂÂÖ¤À¡£
ÆüËܤΥޥ¹¥á¥Ç¥£¥¢ÊóÆ»ÉôÌç¤Î´´Éô¤òºßÆü¤äµ¢²½¿Í¤¬Àê¤á¤Æ¤¤¤ë¾Ú¡£
´Ú¹ñ¤ÎÀ¯Éܵ¡´Ø¤«¤éÆüËܤΥޥ¹¥á¥Ç¥£¥¢¤Ë¶â¤¬Î®¤ì¤Æ¤¤¤ë¾Ú¡£

º£²ó¤ÎÁûư¤ÇÌÀ¤é¤«¤Ë¤Ê¤Ã¤¿¤³¤È¤Ï¡¢´Ú¹ñ¤Ë¾¤Î¹ñ°Ê¾å¤ÎÍ¥¶ø½èÃÖ¤ò¤È¤Ã¤Æ¤Ï¤¤¤±¤Ê¤¤¤È¤¤¤¦¤³¤È¤À¡£


¸í²ò¤À¤é¤±¤Î¡Ö´Ú¹ñ¤ËÂФ¹¤ëÍ¢½Ðµ¬À©È¯Æ°¡×

Æü·Ð¥Ó¥¸¥Í¥¹¡¡7/4(ÌÚ)

¡¡¤Ê¤¼¡¢Áê¼ê¤¬´Ú¹ñ¤Ë¤Ê¤ë¤ÈÆüËܤÎÊ󯻤ÏÏĤó¤Ç¤·¤Þ¤¦¤Î¤À¤í¤¦¡£¤â¤Ã¤ÈÎäÀŤ˻ö¼Â¤òÊ󯻤·¤ÆÍߤ·¤¤¤â¤Î¤À¡£

¡¡º£²ó¤Î¡Ö´Ú¹ñ¤ËÂФ¹¤ëÍ¢½Ðµ¬À©¡×¤Ë´Ø¤·¤Æ¤Ï¡¢¥á¥Ç¥£¥¢¤Ï¡ØÈ¾Æ³ÂκàÎÁ¤ò¡È»ö¼Â¾å¤Î¶ØÍ¢¡È¡Ù¡ØÂдÚÍ¢½Ðµ¬À©¤òȯư¡Ù¤Ê¤É¤È¡¢Í¦¤Þ¤·¤¯Ê󯻤·¤Æ¤¤¤ë¡£¤½¤ì¤ÈƱ»þ¤Ë¡¢µ­»ö¤Ç¤Ï¡¢¡Ø¼«Í³Ëǰפò·Ç¤²¤Æ¤­¤¿ÆüËܤسƹñ¤«¤éÈãȽ¤¬½¸¤Þ¤ë·üǰ¤â¤¢¤ë¡Ù¡Ø³Æ¹ñ¤Ë×ó°ÕŪ¤Ê¥ë¡¼¥ëÊѹ¹¤È¤â¤È¤é¤ì¤«¤Í¤Ê¤¤¡Ù¤È¤¤¤Ã¤¿»ØÅ¦¤â¤·¤Æ¤¤¤ë¡£

¡¡²Ì¤¿¤·¤Æ¤½¤¦¤À¤í¤¦¤«¡£
¡ÊÃæÎ¬¡Ë
¡ü°ÊÁ°¤Î¼ê³¤­¤ËÌ᤹¤â¤Î¤Ç¡ÖÍ¢½Ðµ¬À©È¯Æ°¡×¤Ç¤Ï¤Ê¤¤

¡¡¤Þ¤º¤½¤â¤½¤â¤³¤ì¤Ï¡¢´Ú¹ñ¤ËÂФ·¤Æ¿·¤¿¤Ë¡ÖÍ¢½Ðµ¬À©¤òȯư¡×¤¹¤ë¤â¤Î¤Ç¤Ï¤Ê¤¤¡£´Ú¹ñ¸þ¤±¤ÎÍ¢½Ð¤Ë¤Ä¤¤¤Æ¡¢2004ǯ¤«¤éÆÃÊ̤ËÍ¥¶ø¤·¤Æ´Êά²½¤·¤Æ¤¤¤¿¼ê³¤­¤ò¡¢2003ǯ¤Þ¤Ç¤ÎÉáÄ̤μ곤­¤ËÌ᤹¤â¤Î¤À¡£

´Êά²½¤·¤¿¼ê³¤­¤È¤Ï¡¢3ǯ´ÖÍ­¸ú¤Ê¡ÖÊñ³çµö²Ä¡×¤òÆÀ¤ì¤Ð¡¢¤¤¤Ä¤Ç¤âÍ¢½Ð¤Ç¤­¤ë¤È¤¤¤¦¤â¤Î¤À¡£ËÜÍè¤Ï¡¢Í¢½Ð¤Î·ÀÌ󤴤ȤˡָÄÊ̵ö²Ä¡×¤¬É¬ÍפÀ¡£»ä¤¬Ã´Åö¤·¤Æ¤¤¤¿2003ǯÅö»þ¤Ï¡¢´Ú¹ñ¤Ø¤ÎÍ¢½Ð¤Ï¸ÄÊ̵ö²Ä¤¬É¬ÍפǤ¢¤Ã¤¿¡£¤Þ¤µ¤Ë¤³¤Î»þ¤Î¼ê³¤­¤ËÌ᤹¤Î¤¬º£²ó¤ÎÁ¼ÃÖ¤À¤È¸À¤Ã¤Æ¤è¤¤¡£

¡¡¤Þ¤¿¡¢Í¢½Ð¤ËºÝ¤·¤Æ¡Ö¸ÄÊ̵ö²Ä¡×¤¬É¬ÍפʤΤϡ¢Í¢½Ð´ÉÍý¤ÎÀ¤³¦¤Ç¤Ï¹ñºÝŪ¤Ê¸¶Â§¤Ç¡¢ÆÃÊ̤˿®Íê¤Ç¤­¤ëÁê¼ê¹ñ¤Ë¤Ä¤¤¤Æ¤Î¤ß¡¢¡ÖÊñ³çµö²Ä¡×¤Ë¤è¤ë¼ê³¤­¤Î´Êά²½¤¬Ç§¤á¤é¤ì¤Æ¤¤¤ë¡£¤³¤ÎÂоݹñ¤ò¡¢ÆüËܤÎÀ©Å٤Ǥϡ֥ۥ磻¥È¹ñ¡×¤È¸Æ¤ó¤Ç¤¤¤ë¡£2004ǯ¤Ë¤³¤Î¡Ö¥Û¥ï¥¤¥È¹ñ¡×¤Ë´Ú¹ñ¤¬Äɲ䵤줿¤Î¤À¡£

¡¡¤Ê¤ª¡¢¤³¤Î¸ÄÊ̵ö²Ä¤Ë¤Ä¤¤¤Æ¡¢°ìÉô¤ÎÊóÆ»¤Ç¤Ï¡Ö½Ð²Ù¤´¤È¡×¤Ëµö²Ä¤¬É¬ÍפȤʤꡢÆü¡¹¡¢¹©¾ì¤«¤é´Ú¹ñ¤ËÀ½Éʤò½Ð²Ù¤·¤Æ¤¤¤ë¤è¤¦¤Ê¥Ó¥¸¥Í¥¹¤¬ÄäÂÚ¤·¤Æ¤·¤Þ¤¦¤È¤¤¤¦¤è¤¦¤ÊÊóÆ»¤Ë¤è¤Ã¤Æ¡¢Í¢½Ð´ë¶È¤Î¸½¾ì¤Ïº®Í𤷤Ƥ¤¤ë¤è¤¦¤À¡£

¤³¤ì¤Ï¸í²ò¤Ç¡¢¸ÄÊ̵ö²Ä¤Ï¡É·ÀÌ󤴤ȡɤËɬÍפǡ¢°ì·ÀÌó¤Ç²¿²ó¤Ë¤â½Ð²Ù¤òʬ¤±¤ëÄ̾ï¤Î¥Ó¥¸¥Í¥¹¤ÏÅöÁ³¡¢°ìÅÙ¸ÄÊ̵ö²Ä¤òÆÀ¤Æ¤¤¤ì¤Ð½Ð²Ù¤´¤È¤Ëµö²Ä¤òÆÀ¤ëɬÍפʤ¤¡£
¡ÊÃæÎ¬¡Ë

1990ǯÂå¡¢´Ú¹ñ¤Ï¤Þ¤À¹ñºÝŪ¤ÊÍ¢½Ð´ÉÍý¤ÎÏÈÁȤߤΥá¥ó¥Ð¡¼¤Ç¤Ï¤Ê¤«¤Ã¤¿¡£¡ÊÍ¢½Ð´ÉÍý¤¬½ÐÍè¤Æ¤¤¤Ê¤¤¤¿¤á¡Ë¡£

»ä¤Ï´Ú¹ñ¤¬¤½¤Î¥á¥ó¥Ð¡¼¤Ë»²²Ã¤Ç¤­¤ë¤è¤¦¡¢³Æ¹ñ¤ËƯ¤­¤«¤±¡¢´Ú¹ñ¤Ë¤âºÆ»°Â­¤ò±¿¤ó¤Ç¡¢´Ú¹ñ¤¬Í¢½Ð´ÉÍý¤ò¤·¤Ã¤«¤ê¤Ç¤­¤ë¤è¤¦¤ËÁ´ÌÌŪ¤Ë»Ù±ç¤·¤Æ¤¤¤¿¡£

¤½¤Î·ë²Ì¡¢´Ú¹ñ¤â¹ñºÝÏÈÁȤߤ˥á¥ó¥Ð¡¼¤Ë¤Ê¤ë¤³¤È¤¬¤Ç¤­¡¢´Ú¹ñ¤«¤é¤âÆüËܤΤ½¤ì¤Þ¤Ç¤Î¶¨ÎÏ¡¢Æ¯¤­¤«¤±¤Ë´¶¼Õ¤µ¤ì¤Æ¤¤¤¿¡£¤½¤ì¤¬2004ǯ¤Ë¡¢´Ú¹ñ¤ò¥Û¥ï¥¤¥È¹ñ¤ËÄɲä·¤ÆÆÃÊ̤ËÍ¥¶ø¤¹¤ë¤³¤È¤Ë¤Ä¤Ê¤¬¤Ã¤Æ¤¤¤Ã¤¿¡£

¡ü¡ÖEUʤߡסÖÂÐ¥¤¥ó¥É¥Í¥·¥¢Ê¤ߡפμ곤­¤Ë¤Ê¤ë

¡¡¥Û¥ï¥¤¥È¹ñ¤È¤·¤ÆÆÃÊÌÍ¥¶ø¤¹¤ë¤¿¤á¤Ë¤Ï¡¢Áê¼ê¹ñ¤¬¸·³Ê¤ËÍ¢½Ð´ÉÍý¤ò¤·¤Æ¤¤¤ë¤«¤É¤¦¤«¤ò³Îǧ¤¹¤ë¤¿¤á¤Î¶¨µÄ¤ò¤¹¤ë¤Î¤¬Ä̾ï¤À¡£

¡¡¤½¤¦¤·¤¿¶¨µÄ¤ò¡¢ÆüËܤϲ¤½£¤Ê¤É¾¤Î¥Û¥ï¥¤¥È¹ñ¤È¼Â»Ü¤·¤Æ¤­¤Æ¤¤¤ë¡£¤·¤«¤·¶áǯ¡¢´Ú¹ñ¤À¤±¤Ï¤É¤¦¤¤¤¦¤ï¤±¤«¡¢ÆüËܤȤÎÍ¢½Ð´ÉÍý¤Î¶¨µÄ¤Ë±þ¤¸¤Æ¤¤¤Ê¤¤¤è¤¦¤À¡£

À¯Éܤ¬¡¢¡ÖÍ¥¶ø¤·¤¿¼ê³¤­¤ÎÁ°Äó¤Ë¤Ê¤ëÍ¢½Ð´ÉÍý¤Î¿®Íê´Ø·¸¤¬Êø¤ì¤Æ¤¤¤ë¡×¤È¤·¤Æ¤¤¤ë¤³¤È¤«¤éÁÛÁü¤¹¤ë¤ËÆñ¤¯¤Ê¤¤¡£¤À¤¬¡¢¤³¤ì¤ò¡Ö°ÂÁ´Êݾã¤Îͧ¹¥¹ñ¤Ç¤Ê¤¯¤Ê¤Ã¤¿¡×¤ÈÍý²ò¤¹¤ë¤Î¤Ï¡¢ÌÀ¤é¤«¤Ë¹Ô¤­²á¤®¤Ç¤¢¤ë¡£

¡¡°ÂÁ´Êݾã¤Îͧ¹¥¹ñ¤¬¡Ö¥Û¥ï¥¤¥È¹ñ¡×¤Ç¤¢¤ë¤È²òÀ⤷¤Æ¤¤¤ëÊóÆ»¤â¤¢¤ë¤¬¡¢¤½¤¦¤Ç¤Ï¤Ê¤¤¡£Î㤨¤Ð¡¢¥¤¥ó¥ÉÂÀÊ¿ÍÎÀïά¤ò¶¦Í­¤¹¤ë¥¤¥ó¥É¤ä³¤¾å¶¦Æ±·±Îý¤ò¤¹¤ë¥¤¥ó¥É¥Í¥·¥¢¤Ê¤É¤â¥Û¥ï¥¤¥È¹ñ¤Ç¤Ï¤Ê¤¯¡¢¸ÄÊ̵ö²Ä¤¬É¬ÍפÀ¡£

¡¡¤Þ¤¿²¤½£Ï¢¹ç¡ÊEU¡Ë¤¬Í¢½Ð´ÉÍý¤Î¤¦¤¨¤ÇÆÃÊÌÍ¥¶ø¤·¤Æ¤¤¤ë¤Î¤ÏÆüËܤò´Þ¤á¤Æ8¥«¹ñ¤Ç¡¢¤³¤ì¤Ë´Ú¹ñ¤ÏÆþ¤Ã¤Æ¤¤¤Ê¤¤¡£Â¿¾¯¤ÎºÙ¤«¤¤ÅÀ¤ò̵»ë¤¹¤ì¤Ð¡¢EUʤߤμ곤­¤ËÌᤷ¤¿¤È¤â¸À¤¨¤ë¡£¤½¤ì¤Ç¤É¤¦¤·¤Æ¡Ö¼«Í³Ëǰפ˵չԤ¹¤ë¡×¤È¤ÎÈãȽ¤¬³Æ¹ñ¤«¤é½Ð¤ë¤Î¤À¤í¤¦¤«¡£

¤·¤«¤·Ãæ¹ñ¤Ë¤è¤ë¥ì¥¢¥¢¡¼¥¹¤Î¶ØÍ¢Á¼ÃÖ¤ÈÆ±Îó¤ËÏÀ¤¸¤ë¤Î¤ÏŪ³°¤ì¤À¡£ÆüËܤÏË¡¼£¹ñ²È¤À¡£À¯¼£Åª¤ÊÆ»¶ñ¤È¤·¤ÆË¡Î§±¿ÍѤò¼«Í³¤ËÍøÍѤǤ­¤ë¤â¤Î¤Ç¤Ï¤Ê¤¤¡£

¤¢¤¯¤Þ¤Çº£²ó¤ÎÁ¼Ã֤ϡ¢¼ê³¤­¤ò¡ÖÊñ³çµö²Ä¤«¤é¸ÄÊ̵ö²Ä¤Ø¡×¤È¡¢¸µ¤ËÌ᤹Êѹ¹¤ò¹Ô¤¦¤â¤Î¤À¡£´ð½à¤ò¸¶Â§ÉÔµö²Ä¤Ë¤¹¤ë¤è¤¦ÊѤ¨¤ë¤â¤Î¤Ç¤Ï¤Ê¤¤¡£¤½¤ì¤Ç¤ÏÂй³Á¼Ã֤Ȥ·¤ÆÀ¸¤Ì¤ë¤¤¡¢ÉÔ½½Ê¬¤À¤È¤¤¤¦¤Î¤Ê¤é¤Ð¡¢Êƹñ¤Î¤è¤¦¤Ê¸¶Â§ÉÔµö²Ä¤Ë¤¹¤ë¤è¤¦¤ÊˡΧ¤òµÄ°÷Ωˡ¤Çºî¤ë¤·¤«¤Ê¤¤¤À¤í¤¦¡£

¡¡¡ÖÀ¤³¦Ëǰ׵¡´Ø¡ÊWTO¡Ë¶¨Äê°ãÈ¿¤Îµ¿¤¤¤â¤¢¤ë¥°¥ì¡¼¤ÊÁ¼Ã֡פȤ¹¤ë¡¢¤¢¤ëÆüËܤμ±¼Ô¤Î¥³¥á¥ó¥È¤Þ¤Ç¤¢¤ë¡£

¤À¤¬¡¢2003ǯ¤Þ¤ÇÆüËܤÏWTO°ãÈ¿¤ò¤·¤Æ¤¤¤¿¤È¤Ç¤â¸À¤¦¤Î¤À¤í¤¦¤«¡£ÆüËܤÎÍ¢½Ð´ÉÍýË¡À©¤òÍý²ò¤·¤Æ¥³¥á¥ó¥È¤·¤Æ¤¤¤ë¤È¤Ï»×¤¨¤Ê¤¤¡£

EUʤߤμ곤­¤Ë¤¹¤ë¤³¤È¡¢ÂÐ¥¤¥ó¥É¥Í¥·¥¢Ê¤ߤμ곤­¤Ë¤¹¤ë¤³¤È¤¬¡¢¤É¤¦¤·¤ÆWTO¶¨Äê°ãÈ¿¤Ë¤Ê¤ê¤¨¤ë¤Î¤À¤í¤¦¤«¡£´Ú¹ñ¦¤Î²á¾êÈ¿±þ¤Ë°ú¤ÃÄ¥¤é¤ì²á¤®¤Ç¤Ï¤Ê¤¤¤À¤í¤¦¤«¡£


´Ú¹ñÀ¯ÉܤÎÂåÊÛ¼Ò
¥Æ¥ìÄ«¡§¡Ö°ÂÇܼóÁê¤ÏÃÕÀÛ¤À¡×

£í

¤¬¤ó¤Ë´Ø¤·¤Æ¤Î¿§¡¹¤Êʸ¸¥¤òÆÉ¤ó¤Ç»×¤Ã¤¿¤³¤È¤Ï¡¢ç¯æù¤¬¤ó¤Ë´Ø¤·¤Æ¤Îµ­½Ò¤¬¾¯¤Ê¤¤¤³¤È¤È¡¢ºÆÈ¯¤ò·«¤êÊÖ¤¹ç¯æù¤¬¤ó¤òľÀÜŪ¤Ë¼£¤¹ÊýË¡¤¬Ìµ¤¤¤È¤¤¤¦¤³¤È¤Ç¤¹¡£Íפϡ¢¿©¤Ùʪ¤Ç¤¹¡£

¤â¤¦°ì¤Ä¸À¤¨¤ë¤³¤È¤Ï¡¢ç¯æù¤¬¤ó¤Î¼ç¸¶°ø¤Ï¡¢Êü¼Íǽ¤Î¤è¤¦¤Ç¤¹¡£


Protective effect of Spirulina against cyclophosphamide-induced urotoxicity in mice
Volume 5, Issue 3, September 2018, Pages 191-196

¥Þ¥¦¥¹¤Ë¤ª¤±¤ë¥·¥¯¥í¥Û¥¹¥Õ¥¡¥ß¥ÉͶȯǢÆÇÀ­¤ËÂФ¹¤ë¥¹¥Ô¥ë¥ê¥Ê¤ÎÊݸîºîÍÑ

Âè5´¬¡¢Âè3¹æ¡¢2018ǯ9·î¡¢191-196¥Ú¡¼¥¸

Abstract
ÏÀʸ¤ÎÍ×»Ý
Cyclophosphamide (CP) is an anti-neoplastic drug, which is widely used for treating cancer and non-malignant tumors. 

One of the major side effects of CP is hemorrhagic cystitis. Spirulina (Arthrospira platensis; Sp) is a blue-green algae with the ability to attenuate oxidative stress, which may be utilized for alleviating side effects of chemotherapeutic drugs in the clinic. 

¥·¥¯¥í¥Û¥¹¥Õ¥¡¥ß¥É¡Ê£Ã£Ð¡Ë¤Ï¡¢¹³°­À­¼ðáçÌô¤Ç¤¢¤ê¡¢´â¤ª¤è¤ÓÈó°­À­¼ðáç¤Î¼£ÎŤ˹­¤¯»ÈÍѤµ¤ì¤Æ¤¤¤Þ¤¹¡£

CP¤Î¼ç¤ÊÉûºîÍѤÎ1¤Ä¤Ï½Ð·ìÀ­ç¯æù±ê¤Ç¤¹¡£¥¹¥Ô¥ë¥ê¥Ê¡ÊArthrospira platensis; Sp¡Ë¤Ï¡¢»À²½¥¹¥È¥ì¥¹¤ò·Ú¸º¤¹¤ëǽÎϤò»ý¤ÄÍõÁôÎà¤Ç¡¢¿ÇÎŽê¤Ç²½³ØÎÅË¡Ìô¤ÎÉûºîÍѤò·Ú¸º¤¹¤ë¤¿¤á¤ËÍøÍѤ¹¤ë¤³¤È¤¬¤Ç¤­¤Þ¤¹¡£

The aim of the present study was to evaluate the ability of Sp, to protect mice from cyclophosphamide-induced urotoxicity and hemorrhagic cystitis due to its antioxidant properties. 
Adult female mice were orally administered Sp (600 g/kg body weight/day) over nine days as well as a single dose of CP (40 mg/kg body weight) intraperitoneally either four days previously (CP + Sp group) or four days after the start of Sp intake (Sp + CP group); two further groups were treated with either Sp or CP only, respectively. 

Ëܸ¦µæ¤ÎÌÜŪ¤Ï¡¢¤½¤Î¹³»À²½ÆÃÀ­¤Ë¤è¤ë¥·¥¯¥í¥Û¥¹¥Õ¥¡¥ß¥ÉͶȯÀ­¤ÎÇ¢ÆÇÀ­¤ª¤è¤Ó½Ð·ìÀ­ç¯æù±ê¤«¤é¥Þ¥¦¥¹¤òÊݸ¤ëSp¤ÎǽÎϤòɾ²Á¤¹¤ë¤³¤È¤Ç¤¢¤Ã¤¿¡£

À®ÂλóÀ­¥Þ¥¦¥¹¤Ë¡¢9Æü´Ö¤Ë¤ï¤¿¤Ã¤ÆSp¡Ê600g / kgÂνÅ/Æü¡Ë¡¢¤Ê¤é¤Ó¤Ë4Æü´ÖÁ°¡ÊCP + Sp·²¡Ë¤Þ¤¿¤Ï4Æü´Ö¤Î¤¤¤º¤ì¤«¤Çñ²óÅêÍ¿Î̤ÎCP¡Ê40mg / kgÂνšˤòÊ¢¹ÐÆâÅêÍ¿¤·¤¿¡£ £Ó£ðÀݼ賫»Ï¸å¡Ê£Ó£ð ¡Ü £Ã£Ð·²¡Ë¡£¤µ¤é¤Ë2¤Ä¤Î¥°¥ë¡¼¥×¤Ï¡¢¤½¤ì¤¾¤ìSp¤Þ¤¿¤ÏCP¤Î¤ß¤Ç¼£ÎŤ·¤¿¡£

The results showed that CP induced hemorrhagic cystitis in mice, with levels of malondialdehyde (MAD) significantly increased and those of glutathione (GSH) decreased compared with the control group (P < 0.05), while the opposite effects were observed in the mice who received Sp only (P < 0.05). 

¤½¤Î·ë²Ì¡¢¥·¥¯¥í¥Û¥¹¥Õ¥¡¥ß¥É¡Ê£Ã£Ð¡Ë¤Ï¥Þ¥¦¥¹¤Î½Ð·ìÀ­ç¯æù±ê¤òͶȯ¤·¡¢¥Þ¥í¥ó¥¸¥¢¥ë¥Ç¥Ò¥É¡ÊMAD¡Ë¤Î¥ì¥Ù¥ë¤ÏÂоȷ²¤ÈÈæ³Ó¤·¤ÆÍ­°Õ¤ËÁý²Ã¤·¡¢¥°¥ë¥¿¥Á¥ª¥ó¡ÊGSH¡Ë¤Î¥ì¥Ù¥ë¤Ï¸º¾¯¤·¤¿¤¬¡¢È¿ÂФθú²Ì¤ÏÂоȷ²¤ÈÈæ³Ó¤·¤Æ´Ñ»¡¤µ¤ì¤¿¡£ Sp¤Î¤ß¡ÊP <0.05¡Ë¡£

Furthermore, in the CP + Sp group, MAD and GSH levels were improved compared with those in the CP only group, and in the Sp + CP group, the effects of CP were reversed. 
In addition, histomorphological alterations of the urinary bladder were significantly lower than those in the CP group.

¤µ¤é¤Ë¡¢CP + Sp·²¤Ç¤Ï¡¢MAD¡ÊÃ𣱡ˤª¤è¤Ó¥°¥ë¥¿¥Á¥ª¥ó¡ÊGSH¡Ë¡ÊÃ𣲡˥ì¥Ù¥ë¤ÏCPñÆÈ·²¤Î¤½¤ì¤é¤ÈÈæ³Ó¤·¤Æ²þÁ±¤µ¤ì¡¢Sp + CP·²¤Ç¤Ï¡¢CP¤Î¸ú²Ì¤ÏµÕž¤·¤¿¡£

¡ÊÃ𣱡ËMAD
¤¢¤ëÆÃÄê¤Î¸¶»Ò¤Î°Û¾ï»¶Íð¹à¤òÊ£¿ô¤ÎÇÈŤÎXÀþ¤òÍѤ¤¤ÆÂ¬Äꤷ¡¤¤½¤Î¥·¥°¥Ê¥ë¤òÍøÍѤ·¤Æ¹½Â¤²òÀϤò¹Ô¤¦Â¿ÇÈĹ°Û¾ïʬ»¶¡ÊMAD¡ËË¡

¡ÊÃ𣲡˥°¥ë¥¿¥Á¥ª¥ó¡ÊGSH¡Ë
¹âÅùư¿¢Êª¤«¤éÈùÀ¸Êª¤Þ¤Ç¡¤À¸Êª³¦¤Ë¹­¤¯Ê¬ÉÛ¤¹¤ëÅ·Á³¤Î¹³»À²½Êª¼Á¡ÊÀ¸ÂÎÆâ´Ô¸µÊª¼Á¡¢Êä¹ÚÁǡˡ£³èÀ­»ÀÁǼï¤Î½üµî¡Ê¹³»À²½¡Ë¤ä¡¤µáÅÅ»ÒŪ¤Ê²½¹çʪ¡¤½Å¶â°¤Ê¤ÉÀ¸ÂΰÛʪ¡ÊÆÇʪ¡Ë¤Î²òÆÇ¤ÎºÇÁ°Àþ¤ËΩ¤Ä¶Ë¤á¤Æ½ÅÍפÊʬ»Ò¤Ç¤¢¤ê¡¤»À²½¥¹¥È¥ì¥¹¤ò²ð¤·¤Æ¤¬¤ó²½³ØÎÅË¡¤«¤éÌôºÞÂÑÀ­¡¤À¸³è½¬´·É¤˻ê¤ë¤Þ¤Ç¡¤ÉÂÂ֤ȿ¼¤¯¤«¤«¤ï¤ë¡£

¤µ¤é¤Ë¡¢ç¯æù¤ÎÁÈ¿¥·ÁÂÖ³ØÅªÊѲ½¤Ï¡¢¥·¥¯¥í¥Û¥¹¥Õ¥¡¥ß¥É¡ÊCP¡Ë·²¤Î¤â¤Î¤è¤ê¤âÍ­°Õ¤ËÄ㤫¤Ã¤¿¡£

 In conclusion, pre-treatment with Sp protected mice from CP-induced urotoxicity, probably via its anti-oxidant and anti-apoptotic properties.

·ëÏÀ¤È¤·¤Æ¡¢Sp¡Ê¥¹¥×¥ë¥ê¥Ê¡Ë¤Ë¤è¤ëÁ°½èÍý¤Ï¡¢¤ª¤½¤é¤¯¤½¤Î¹³»À²½¤ª¤è¤Ó¹³¥¢¥Ý¥È¡¼¥·¥¹¡ÊÃð£³¡ËÆÃÀ­¤ò²ð¤·¤Æ¡¢¥·¥¯¥í¥Û¥¹¥Õ¥¡¥ß¥É¡Ê£Ã£Ð¡ËͶȯÀ­¤ÎÇ¢ÆÇÀ­¤«¤é¥Þ¥¦¥¹¤òÊݸ¤¿¡£

¡ÊÃ𣳡˹³¥¢¥Ý¥È¡¼¥·¥¹
´Êñ¤Ë¸À¤¨¤Ð¡¢¡ÖºÙ˦»àËɸæ¡×¡£¥¢¥Ý¥È¡¼¥·¥¹¡ÊApoptosis¡Ë¤È¤Ï¥Í¥¯¥í¡¼¥·¥¹¡ÊNecrosis¡Ë¤ÈƱÍÍ¡¢ÂåɽŪ¤ÊºÙ˦»à¡£ºÙ˦Æâ¤Çµ¯¤³¤ë°ìÏ¢¤Îʬ»Ò¥ì¥Ù¥ë¤ÎÈ¿±þ¤Ë¤è¤ëºÙ˦»à¡£ºÙ˦À¸Â¸¤Î°Ù¤ËÀѶËŪ¤Ë¥¢¥Ý¥È¡¼¥·¥¹¤òÍÞÀ©¤¹¤ë¤Î¤¬¹³¥¢¥Ý¥È¡¼¥·¥¹°ø»Ò¡£

¡¡¡¡¡¡¡ú¡¡¡¡¡¡¡ú¡¡¡¡¡¡¡ú
¡Ø¥¹¥Ô¥ë¥ê¥Ê¡§ÂÎÆâ¤«¤éÊü¼Íǽ½üµî¡Ù¡¡2019/7/1(·î) 
¡ØSP¡Ê¥¹¥Ô¥ë¥ê¥Ê¡Ë¤ÎÊݸî¸ú²Ì¡§¿Õ¡¡õ´Î¡ÆÇÀ­¡Ù¡¡2019/7/3(¿å)
¡¡¡¡¡¡¡ú¡¡¡¡¡¡¡ú¡¡¡¡¡¡¡ú

¡Ê½é¤á¤Ë¡Ë°Ê²¼¤ÏÂθ³µ­¤Ç¤¹¤¬¡¢µ¡³£¸ìÌõ¤Î¤Þ¤Þ¤Ç¤¹¡£ç¯æù¤¬¤ó¤ËÂФ·¤Æ¤ÎÆÃ¸úÌô¤Ï¤¢¤ê¤Þ¤»¤ó¤¬¡¢·Ñ³Ū¤ËSp¡Ê¥¹¥×¥ë¥ê¥Ê¡Ë¤â´Þ¤àÌîºÚ¤ÎÀݼè¤Ç¤Î¥¢¥ë¥«¥ê²½¤Ç¤¹¡£

¥Õ¡¼¥É¥­¥ë¥¬¥ó
¥¸¥§¥Õ¡¦¥¦¥£¥Ä¥Þ¥ó
2015ǯ11·î17Æü 

I¡Çve witnessed first hand the killing of cancer with food. 
»ä¤ÏľÀÜŪ¤Ë¿©Êª¤Ë¤è¤ë´â¤Î»¦³²¤òÌܷ⤷¤¿
¡ÊÃæÎ¬¡Ë

Í×Ì󤹤ë¤È¡¢
»ä¤ÎºÊ¤Î¥±¥ê¡¼¤ÏII´ü¤Îç¯æù´â¤È¿ÇÃǤµ¤ì¤¿¡£¥´¥ë¥Õ¥Ü¡¼¥ë¥µ¥¤¥º¤Î¼ðáç¤òÀÚ½ü¤·¤¿¤¬¡¢Ù¨Ê¿¾åÈé´â¤¬¶ÚÆùÊɤ˿»½á¤·¤Æ¤¤¤¿¡£¤³¤³¥í¥µ¥ó¥¼¥ë¥¹¤ÎÈçÇ¢´ï²Ê°å¤ÏÍ£°ì¤Î²ò·èºö¤ò½èÊý¤·¤¿¡§

ç¯æù½üµî¡¢Â³¤¤¤ÆÇ¢¤Î¤¿¤á¤ÎÇ¢´ÉÀÚ³«½Ñ¥Ð¥Ã¥°¡¢¤½¤ì¤Ë³¤¯²½³ØÎÅË¡¤ÈÊü¼ÍÀþÎÅË¡¡£¤½¤ÎÂå¤ï¤ê¤Ë²æ¡¹¤Ï28,000¥É¥ë¤òʧ¤¤½Ð¤·¡¢¥É¥¤¥Ä¤Ë¹Ô¤­¡¢¤½¤·¤Æ¤½¤ì¤ò¼«Á³ÎÅˡŪ¤Ë¼£ÎŤ·¡¢¤½¤ì¤ò30Æü°ÊÆâ¤Ë̵Äˤǻ¦¤·¤¿¡£²½³ØÎÅË¡¡¢Êü¼ÍÀþ¡¢º¬¼£¼ê½Ñ¤Ï¤Ê¤¤¡£

¤½¤ÎÂå¤ï¤ê¤Ë¡¢²¹Ç®ÎÅË¡¡Ê¾ÇÅÀ105ÇÜÇ®¡Ë¤È¥ª¥¾¥óÎÅË¡¤¬¡¢¥Ó¥¿¥ß¥ó¡¢¥ß¥Í¥é¥ë¡¢¥¢¥ß¥Î»À¤ÎÃíÆþ¤È¶¦¤Ë¹Ô¤ï¤ì¤¿¡£

¤·¤«¤·¡¢µ¢¹ñ¤·¤Æ1¥õ·î¸å¤Ë¡¢»ä¤¿¤Á¤Ï¿·¤·¤¤¼«Á³ÎÅË¡¤Ë¤ä¤µ¤·¤¤ÈçÇ¢´ï²Ê°å¤È¥Õ¥©¥í¡¼¥¢¥Ã¥×ˬÌä¤ò¹Ô¤¤¡¢¾®¤µ¤Ê´âÀ­¥Ý¥ê¡¼¥×¤òȯ¸«¤·¤Þ¤·¤¿¡£

¸Å¤¤ÀѶËŪ¤Ê٨ʿ¾åÈé´â¤Î¤É¤ì¤â¡¢¤Þ¤À´âÀ­¤Ç¤Ï¤¢¤ê¤Þ¤»¤ó¡£¥Ý¥ê¡¼¥×¤ÏÁߤ­¼è¤é¤ì¤Þ¤·¤¿¤¬¡¢¤É¤ó¤Ê¼ïÎà¤Î´â¤ÎºÆÈ¯¤âÈó¾ï¤ËÌñ²ð¤Ç¤·¤¿¡£

¥±¥ê¡¼¤Ï¡¢Í£°ì¤Î¹ÔưÊý¿Ë¤Ï¡¢´â¤È¤ÎĹ´üŪ¤ÊÆ®¤¤¤Ë¤ª¤±¤ë½ÅÍפÊÍ×ÁǤȤ·¤Æ¿©Êª¤òÇÜÁý¤¹¤ë¤³¤È¤Ç¤¢¤ë¤È·è¤á¤Þ¤·¤¿¡£

¿ÍÂΤ¬40ºÐ¤ò²á¤®¤ë¤È¡¢ºÇÂçǽÎÏ¤ÇÆ°ºî¤¹¤ë¤¿¤á¤ËɬÍפʤâ¤Î¤ÎÀ½Â¤¤¬Ãæ»ß¤µ¤ì¤Þ¤¹¡£¤½¤Î¤¿¤á¡¢¥µ¥×¥ê¥á¥ó¥È¤ä±ÉÍܲÁ¤Î¹â¤¤¿©Éʤ«¤é¤Î±ç½õ¤¬É¬ÍפǤ¹¡£»ä㤬Áª¤ó¤À¤½¤·¤Æ»äã¤Î¤¿¤á¤ËƯ¤¯Æ»¤Ï¡¢

ÂÎÆâ¤Î¥¢​​¥ë¥«¥ê¥ì¥Ù¥ë¤òÊѤ¨¤ë¤¿¤á¤Ë¥¢¥ë¥«¥ê¤ò·ÁÀ®¤¹¤ë¿©Êª¤ò¸«¤Ä¤±¤ë¤³¤È¤Ç¤¹¡£¤½¤ì¤Ï¤¿¤¯¤µ¤ó¤ÎÎФȲ̼¡¢Á´Î³¹òʪ¤ÈƦ¤È¤è¤ê¾¯¤Ê¤¤Æù¤ò¿©¤Ù¤ë¤³¤È¤ò°ÕÌ£¤·¤Þ¤¹¡£

Èà½÷¤Ï¥¢¥Þ¥¾¥ó¤«¤é¥¢¥ë¥«¥êÀ­¥Æ¥¹¥È¥¹¥È¥ê¥Ã¥×¤òÆþ¼ê¤·¡¢Èà½÷¤¬7.0¤ÎÈϰϤޤ¿¤Ï¤½¤ì°Ê¾å¤Îph¥ì¥Ù¥ë¤òÆÀ¤ë¤³¤È¤¬¤Ç¤­¤ë¤Þ¤ÇËèÄ«Èà½÷¤ÎÇ¢¤ò¥Æ¥¹¥È¤·¤Þ¤·¤¿¡£

¤â¤Ã¤È¶ñÂÎŪ¤ËÀâÌÀ¤¹¤ë¤Ä¤â¤ê¤Ç¤¹¤¬¡¢ºÇ½é¤Ë²ûµ¿ÏÀ¼Ô¤Ë°ì¸À¡£Minnesota Oncology¤Î¤è¤¦¤Ê¥µ¥¤¥È¤Ï¡¢´â¤¬¥¢¥ë¥«¥êÀ­¤Î¹â¤¤´Ä¶­¤Ç¤Ï¸ºß¤Ç¤­¤Ê¤¤¤È¤¤¤¦¥ª¥Ã¥È¡¼¥¦¥©¡¼¥Ö¥ë¥°¤Î¥Î¡¼¥Ù¥ë¾Þ¤Î¡Ö¿ÀÏáפòÀëÅÁ¤¹¤ë¤Î¤¬Âç¹¥¤­¤Ç¤¹¡£

Èà¤é¤Ï¤½¤ì°ÊÍè´âºÙ˦¤Ë¤Ä¤¤¤ÆÂ¿¤¯¤ò³Ø¤ó¤Ç¤­¤¿¤ÈÈà¤é¤Ï¸À¤¦¡£¤·¤«¤·¡¢¤¢¤Ê¤¿¤¬²¿¤ò¿©¤Ù¤ë¤Ù¤­¤«¤È¤¤¤¦Èà¤é¤ÎÄó°Æ¤Ë¹Ô¤¯¤È¤­¡£¡£¡£Èà¤é¤Ï¥¢¥ë¥«¥êÀ­¤Î¹â¤¤¿©Éʤò¿©¤Ù¤ë¤³¤È¤òÄ󰯤·¤Þ¤¹¡£

¤½¤ì¤Ç»ä¤Ï¤½¤ì¤¬Èà¤é¤¬ÂÐÏäò¥³¥ó¥È¥í¡¼¥ë¤·¡¢Èà¤é¼«¿È¤òÀìÌç²È¤Ë¤·¤½¤·¤Æ¿Í¡¹¤ò125²¯¥É¥ë¤Î¥±¥â¤È¥±¥âÌôʪ´â¼£ÎÅ»º¶È¤Ë°Í¸¤µ¤»Â³¤±¤ë¤³¤È¤ò°¦¤¹¤ë¤È¤¤¤¦¥·¥°¥Ê¥ë¤È¤·¤Æ¤½¤ì¤ò¼è¤ê¤Þ¤¹¡£

¥±¥ê¡¼¤Î¤¿¤á¤Ë¡¢ËèÄ«¤Ï¤¿¤¯¤µ¤ó¤ÎÌîºÚ¡¢ÌîºÚ¤È²Ì¼Â¤Ç¤¤¤Ã¤Ñ¤¤¤Î¥Ë¥å¡¼¥È¥ê - ÃÆ´Ý¥¹¥à¡¼¥¸¡¼¤Ç»Ï¤Þ¤ê¤Þ¤¹¡£

¤µ¤é¤Ë¡¢¡ÖBudwig Protocol¡×¤È¸Æ¤Ð¤ì¤ë¤â¤Î¤¬º®¹ç¤µ¤ì¤Æ¤¤¤Þ¤¹¡£¤½¤ì¤Ï°¡Ëã¿ÎÌý¤ÈÍ­µ¡¥«¥Ã¥Æ¡¼¥¸¥Á¡¼¥º¤ÎÁȤ߹ç¤ï¤»¤Ç¡¢´â¤Ï»ÀÁǤò·ù¤¦¤¿¤á¡¢ºÙ˦¤Ë»ÀÁǤò¶¡µë¤·¤Þ¤¹¡£

º£Æü¤Î¥¹¥à¡¼¥¸¡¼¡Ê¼Ì¿¿¡Ë¤Ë¤Ï¡§¥³¥³¥Ê¥Ã¥Ä¿å¡¢¥±¥Õ¥£¥¢¡¢É¹¤È¿å¡¢¥±¡¼¥ë¡¢¥»¥í¥ê¡¢ÀÄ¥ê¥ó¥´¡¢ÎäÅà¥Ñ¥¤¥Ê¥Ã¥×¥ë¡¢¥ß¥ó¥È¡¢¥Ö¥í¥Ã¥³¥ê¡¼¡¢²ê¥­¥ã¥Ù¥Ä¡¢¥ë¥Ã¥³¥é¡¢¥Ë¥ó¥¸¥ó¡¢²Ì¼Â¡¢À¸Õª¡¢¥¿¡¼¥á¥ê¥Ã¥¯¡¢¥Ê¥Ã¥Ä¡Ê¥ß¥Ã¥¯¥¹¡Ë¡¢¼ï»Ò¡Ê°¡Ëã¡¢ÂçËã¡¢¥Á¥¢¡Ë¡¢¥´¥¸¥Ù¥ê¡¼¡¢¤½¤·¤Æ¥¢¥×¥ê¥³¥Ã¥È¤Î³Ë¡Ê4¡Ë¡£¡Ê¼Ì¿¿¤Ë¤Ï¼Ì¤Ã¤Æ¤¤¤Þ¤»¤ó¤¬¡¢ÉÑÈˤËÄɲäµ¤ì¤Æ¤¤¤Þ¤¹ - ¥¿¥ó¥Ý¥Ý¤ÎÎС£¤¢¤Þ¤ê¤Ë¤â¶ì¤¤¾ì¹ç¤Ï¡¢¤ªÃã¤òºî¤ë¤¿¤á¤Ë¤½¤ì¤é¤ò»ÈÍѤ¹¤ë¤³¤È¤¬¤Ç¤­¤Þ¤¹¡£¡Ë

Amazon¤Ç¹ØÆþ¤·¤¿¥¢¥×¥ê¥³¥Ã¥È¥«¡¼¥Í¥ë¤Ë´Ø¤¹¤ë¥á¥â¡£¤½¤ì¤¬ÀøºßŪ¤Ë´í¸±¤Ç¤¢¤ë¤¿¤á¤Ë¤Ï10°Ê¾å/Æü¤ò¿©¤Ù¤Ê¤±¤ì¤Ð¤Ê¤é¤Ê¤¤¤Ç¤·¤ç¤¦¡£¤³¤Î¾¯ÎÌ¡Ê4¡Ë¤Ç¤Ï¡¢¥Ó¥¿¥ß¥óB17¤¬´Þ¤Þ¤ì¤Æ¤ª¤ê¡¢¶¯ÎϤʹ³¤¬¤óºÞ¤Ç¤¹¡£

¤Ï¤¤¡¢»ä¤ÏÏÀµÄ¤ò¸Æ¤ó¤Ç¤¤¤ë²½³ØÌôÉÊ¥¤¥Í¡¼¥Ö¥é¤¬ÈùÎ̤Υ·¥¢¥ó²½Êª¤Ë¤Ä¤¤¤ÆÁߤ­Î©¤Æ¤ë¤³¤È¤ò¹¥¤à¤Î¤òÃΤäƤ¤¤Þ¤¹¡£»ä¤Ï¤½¤ì¤òÄ´¤Ù¤Þ¤·¤¿¡£¥±¥ê¡¼¤Ï¤½¤ì¤ÇÂç¾æÉפǤ¹¡£¤¢¤Ê¤¿¤ÏƱ¤¸¤³¤È¤ò¤¹¤ë¤«¤â¤·¤ì¤Þ¤»¤ó¡£

¡Ê²èÁü¡ËBudwig¥×¥í¥È¥³¥ë
²Ã¤¨¤Æ¡¢¥±¥ê¡¼¤Ï¤³¤ì¤é¤Î¥µ¥×¥ê¥á¥ó¥È¤ò¼è¤ê¤Þ¤¹¡§Ìȱ֥·¥¹¥Æ¥à¤ò¸å²¡¤·¤¹¤ë¤¿¤á¤Ë¡Ê¥È¥é¥ó¥¹¥Õ¥¡¡¼¥Ý¥¤¥ó¥È¤Ë¤è¤Ã¤Æ¡Ë¥Ù¡¼¥¿1,3D¥°¥ë¥«¥ó¡£Barley Power - ÂÎÆâ¤Î¥¢¥ë¥«¥êÀ­¥ì¥Ù¥ë¤ò¹â¤á¤ë¤Î¤ò½õ¤±¤ë¤¿¤á¤ÎÎФκǹâ¤Î¥¿¥Ö¥ì¥Ã¥È¤È¥¹¥Ô¥ë¥ê¥Ê¤Î¥¿¥Ö¥ì¥Ã¥È¡£

ÈùÎ̱ÉÍÜÁǤηì±Õ¸¡ºº¤ÏÈà½÷¤ÎÂΤΥ¯¥í¥à¤È¥Ó¥¿¥ß¥óA¤ÎÉÔ­¤òÌÀ¤é¤«¤Ë¤·¤¿¤Î¤ÇÈà½÷¤Ï¤½¤ì¤òƱÍͤËÉÕ¤±²Ã¤¨¤Þ¤¹¡£

Á´ÂÎŪ¤Ë»ä¤¿¤Á¤ÏÀÖ¿È¤ÎÆù¡¢ÌîºÚ¡¢ÌîºÚ¡¢ÆýÀ½ÉÊ¡¢¾®Çþ¡¢¤½¤·¤ÆÁ´Î³Ê´¤ò¿©¤Ù¤Æ¤¤¤Þ¤¹¡£»ä¤¿¤Á¤Ï¹ü¥¹¡¼¥×¤òºî¤ê¡¢Ä²¤Î¤¿¤á¤Ë¤¿¤¯¤µ¤ó¤Î¥×¥í¥Ð¥¤¥ª¥Æ¥£¥¯¥¹¤ò¿©¤Ù¤Æ¤¤¤Þ¤¹¡£¡£¡£

¥¶¥ï¡¼¥¯¥é¥¦¥È¡¢¥±¥Õ¥£¥¢¡¢¥³¥ó¥Ö¥Á¥ã¡¢¤ª¤è¤Ó¹ÚÁÇ¥µ¥×¥ê¥á¥ó¥È¤ÎÉþÍÑ¡£¤½¤ì¤¬Ìþ¤¹¤¿¤á¤ËɬÍפʤâ¤Î¤òÆÀ¤ë¤¿¤á¤ËIJ¤ÏÂΤ¬¤¦¤Þ¤¯µ¡Ç½¤·¤Ê¤±¤ì¤Ð¤Ê¤ê¤Þ¤»¤ó¡£¤µ¤é¤Ë»äã¤Ï»äã¤ÎÂΤ¬¤â¤Ï¤äºî¤ê½Ð¤µ¤Ê¤¤Êä­¤òÆÀ¤ë¤¿¤á¤Ë±ÉÍܻΤȲñ¤¦¡£

´â¤òµ²¤¨¤µ¤»¤ë¤³¤È¤Ï²Äǽ¤Ç¤¹¡£ÀºÏ£¤µ¤ì¤¿º½Åü¤ä²Ã¹©¿©Éʤ¬¤Ê¤¤¤È¤¤¤¦°ìÈÌŪ¤Êµ¬Â§¤Ï¡¢¤½¤ì¤é¤¬»ê¤ë¤È¤³¤í¤Ë¤¢¤ë¤Î¤Ç¼ÂºÝ¤Ë¤ÏÆñ¤·¤¤¤³¤È¤â¤¢¤ê¤Þ¤¹¤¬½¾¤¦¤Ù¤­¤â¤Î¤Ç¤¹¡£

¤½¤·¤Æ¡¢¤Ï¤¤¡¢»ä¤¿¤Á¤Ï¤¿¤Þ¤Ë¥«¥ó¥Ë¥ó¥°¡ÊÉⵤ¡¢¥º¥ë¡Ë¤·¤Þ¤¹¡£À¸³è¤Î¼Á¤¬½ÅÍפǤ¢¤ë¤Î¤Ç¡¢¥±¡¼¥­¤ÎÇö¤¤¥¹¥é¥¤¥¹¡¢¥«¥¯¥Æ¥ë¡¢¤Þ¤¿¤Ï¿À¤¬¶Ø¤¸¤ë¡¢¥Ô¥¶¤Ï»þÀÞµ¯¤³¤ë¡£

¤·¤«¤·¡¢¥Ý¥ê¡¼¥×¤¬È¯¸«¤µ¤ì¤Æ²ò¤­Êü¤¿¤ì¤Æ¤«¤é2¥õ·î¸å¤Ë¡¢¿·¤·¤¤´â¤ÏÀ®Ä¹¤·¤Æ¤¤¤Þ¤»¤ó¤Ç¤·¤¿¡¢¤½¤·¤Æ¡¢»ä¤Ï¤½¤ì¤ò±ÉÍܤÎÊѲ½¤Ëµ¢¤¹¤³¤È¤¬¤Ç¤­¤ë¤À¤±¤Ç¤¹¡£¤µ¤é¤Ë¡¢¥±¥ê¡¼¤Î»ÐËå¤Ï4ǯ´ÖƱ¤¸¥×¥í¥È¥³¥ë¤ò¹Ô¤¤¡¢ºÇ½é¤Ë¥É¥¤¥Ä¤Ç¤â¼£ÎŤµ¤ì¤Æ¤¤¤¿Èà½÷¤Î¥¹¥Æ¡¼¥¸IV¤Î°­À­¹õ¿§¼ð¤«¤é´â¤Î¤Ê¤¤¤Þ¤Þ¤Ç¤¤¤Þ¤·¤¿¡£

¤Þ¤¿¡¢Kerry¤Î¥×¥í¥È¥³¥ë¤ÎÉû»ºÊª¤¬¡¢È©¤ò¤è¤êÁ¯ÌÀ¤Ë¤·¡¢ÀÅÌ®¤Î½Û´Ä¤òÎɤ¯¤·¡¢¤½¤·¤Æ¡Ö¤É¤¦¤·¤Æ¤½¤ó¤Ê¤ËÈþ¤·¤¯¸«¤¨¤ë¤Î¤«¡×¤È¤¤¤Ã¤¿¤â¤Î¤¬Æ±Î½¤«¤é¤Î¥³¥á¥ó¥È¤Ç¤¢¤ë¤³¤È¤âÃíÌܤËÃͤ¹¤ë¡£

¤³¤ì¤Ï¤Û¤ó¤Î°ìÏäǤ¹¡£¤¢¤Ê¤¿¼«¿È¤Î·Ð¸³¤òÄó½Ð¤·¤Æ¡¢¤¢¤Ê¤¿¤Ë¤È¤Ã¤ÆÌòΩ¤Ä¤â¤Î¤Ë¤Ä¤¤¤Æ¤Î²ñÏä˻²²Ã¤·¤Æ¤¯¤À¤µ¤¤¡£²æ¡¹¤Ï¡¢¥Ý¥Ã¥É¥­¥ã¥¹¥È¤ò¼çºÅ¤·¡¢±ÉÍܤˤĤ¤¤Æ¤Î¾ðÊó¤Î¿¤¯¤Ë¤Ä¤¤¤Æcancertutor.com¤Ç¸«¤Ä¤±¤é¤ì¤ë¤³¤È¤¬¤Ç¤­¤ë¥Ó¥ë¡¦¥Ø¥ó¥À¡¼¥½¥ó¤ËÈó¾ï¤Ë´¶¼Õ¤·¤Æ¤¤¤Þ¤¹¡£

»ä¤¿¤Á¤Î¼£ÎŤˤĤ¤¤Æ¤Î»ä¤ÎºÇ½é¤Îʪ¸ì¤Ï¡¢¼¡¤Î¾ì½ê¤Ë¤¢¤ê¤Þ¤¹¡£https : //medium.com/@jeffwitzeman/so-it-turns-out-cancer-can-be-killed-after-all-32764ac8d6db


¡ØÍ­µ¡ÌîºÚ¤Ï¤¬¤ó¡Ê¿¿¶Ý¡Ë¤ò»¦¤¹¡Ù¡¡2018/7/7(ÅÚ) 
²Ìʪ¤äÌîºÚ¤Ï¤¬¤ó¡Ê¿¿¶Ý¡Ë¤ËØí´µ¤·¤Ê¤¤¡£¤½¤ì¤Ï¡¢¿¿¶Ý¤Î½Ð¸½¤ËÂФ·¤Æ¤Î¤ß½ÐÍè¤ë¤¢¤ëÆÃ¼ì¤Ê¹ÚÁǤ¬¿¿¶Ý¤ò»¦¤¹¤«¤é¤À¡£¸Î¤Ë¡¢ÇÀÌô¤Ç¿¿¶Ý¤ò»¦¤·¤Æ¤·¤Þ¤Ã¤¿¤é¡¢¤³¤ÎÆÃ¼ì¹ÚÁǤϽÐÍè¤Ê¤¤¡£

À¸ÌîºÚ¤ä²Ìʪ¤ò¿©¤Ù¤ë²ÁÃͤϤ³¤³¤Ë¤¢¤ë¡£¤³¤Î¹³¤¬¤ó¹ÚÁǤò¿©¤Ù¤ë¤³¤È¤Ë¤Ê¤ë¤«¤é¤À¡£Ã¢¤·¡¢ÇÀÌô¤ò»ÈÍѤ·¤Ê¤¤Í­µ¡ºÏÇݤÀ¤±¤À¤¬¡£

¡ØºÇ¶á¡¢ÂÎÄ´¤Î°­¤¤Êý¤Ø¡Ù¡¡2012/10/3(¿å) 
¹¶¤á¤Î¿©ºà¤â¼é¤ê¤Î¿©ºà¤â¡¢ÌîºÚ¤ä²Ìʪ¡¢¹òʪ¤Ê¤É¤Î¿¢ÊªÀ­¤Î¤â¤Î¤¬Ãæ¿´¤Ç¤¹¡£Îв«¿§ÌîºÚ¤¬¤«¤é¤À¤Ë¤¤¤¤¤È¤¤¤¦¤³¤È¤Ï¤è¤¯ÃΤé¤ì¤Æ¤¤¤Þ¤¹¤¬¡¢¼Â¤Ï¡¢ÌȱÖÎϤò¥¢¥Ã¥×¤µ¤»¤ë¤¿¤á¤Ë¤Ï¡¢Â纬¤ä¥«¥ê¥Õ¥é¥ï¡¼¤Ê¤É¤Îø¿§ÌîºÚ¤Î¤Û¤¦¤¬¤¹¤°¤ì¤Æ¤¤¤ë¤Î¤Ç¤¹¡£
 
¤½¤ÎÍýͳ¤Ï¡¢ÌȱÖÎϤò¥¢¥Ã¥×¤µ¤»¤ë*¡Ö¥Õ¥¡¥¤¥È¥±¥ß¥«¥ë¡×¤È¤¤¤¦À®Ê¬¤¬¤¿¤Ã¤×¤ê´Þ¤Þ¤ì¤Æ¤¤¤ë¤«¤é¤Ê¤Î¤Ç¤¹¡£Îв«¿§ÌîºÚ¤À¤±¤Ç¤Ï¤Ê¤¯¡¢¥Ë¥ó¥Ë¥¯¡¢¥¿¥Þ¥Í¥®¡¢¥Ö¥í¥Ã¥³¥ê¡¼¡¢¥À¥¤¥³¥ó¡¢¥­¥ã¥Ù¥Ä¤Ê¤É¤Îø¿§ÌîºÚ¤â¥Ð¥é¥ó¥¹¤è¤¯¿©¤Ù¤Þ¤·¤ç¤¦¡£


¥°¥ë¥¿¥Á¥ª¥óÂå¼Õ¤È¥Á¥ª¡¼¥ë¥±¥ß¥¹¥È¥ê¡¼¡½ÉÂÂ֤Ȥδط¸¡¤ÁÏÌôɸŪ¤È¤·¤Æ¤Î²ÁÃÍ

£í

Á´1¥Ú¡¼¥¸

[1]


.
¥¢¥Ð¥¿¡¼
¿å̵À¥¤è¤ê
Èó¸ø³« / Èó¸ø³«
¿Íµ¤ÅÙ
Yahoo!¥Ö¥í¥°¥Ø¥ë¥× - ¥Ö¥í¥°¿Íµ¤Å٤ˤĤ¤¤Æ
Æü ·î ²Ð ¿å ÌÚ ¶â ÅÚ
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 31

¥Ö¥í¥°¥Ð¥Ê¡¼

Yahoo!¤«¤é¤Î¤ªÃΤ餻

¸¡º÷ ¸¡º÷

²áµî¤Îµ­»ö°ìÍ÷

¥¹¥Þ¡¼¥È¥Õ¥©¥ó¤Ç¸«¤ë

¥â¥Ð¥¤¥ëÈÇYahoo!¥Ö¥í¥°¤Ë¥¢¥¯¥»¥¹¡ª

¥¹¥Þ¡¼¥È¥Õ¥©¥óÈÇYahoo!¥Ö¥í¥°¤Ë¥¢¥¯¥»¥¹¡ª

ɸ½à¥°¥ë¡¼¥×

¤è¤·¤â¤È¥Ö¥í¥°¥é¥ó¥­¥ó¥°

¤â¤Ã¤È¸«¤ë

[PR]¤ªÆÀ¾ðÊó

¤Õ¤ë¤µ¤ÈǼÀÇ¥µ¥¤¥È¡Ø¤µ¤È¤Õ¤ë¡Ù
11¡¿30¤Þ¤Ç£µ¼þǯµ­Ç°¥­¥ã¥ó¥Ú¡¼¥óÃæ¡ª
Amazon¥®¥Õ¥È·ô1000±ßʬÅö¤¿¤ë¡ª
¤ªÆù¡¢µû²ð¡¢¤ªÊÆ¡¢¤ª¤»¤Á¤Þ¤Ç
¤ª¤¹¤¹¤áÆÃ»ºÉʤ¬¥é¥ó¥­¥ó¥°¤ÇÁª¤Ù¤ë
¤Õ¤ë¤µ¤ÈǼÀÇ¥µ¥¤¥È¡Ø¤µ¤È¤Õ¤ë¡Ù

¤½¤Î¾¤Î¥­¥ã¥ó¥Ú¡¼¥ó


¤ß¤ó¤Ê¤Î¹¹¿·µ­»ö